Frontiers in Cardiovascular Medicine

JANUARY 21, 2025

Atrial fibrillation is the most prevalent arrhythmia with a lifetime risk of nearly 30%. Additional advantages include providing electrophysiology lab personnel with a lead-free working environment and avoiding radiation exposure for both patients and physicians.

Atrial Fibrillation 52

Atrial Fibrillation Quality of Life Ablation Electrophysiology 52

Frontiers in Cardiovascular Medicine

FEBRUARY 21, 2024

Evidence suggests a reduced incidence of ventricular and atrial arrhythmias in patients with dapagliflozin or empagliflozin treatment. It is unclear to what extent the reduced arrhythmia burden is due to direct effects of the SGLT2 inhibitors or is solely a marker of improved cardiac function.

Electrophysiology 59

Electrophysiology Atrial Fibrillation Arrhythmia Cardiac Function 59

Circulation: Arrhythmia and Electrophysiology

FEBRUARY 24, 2025

Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:The strongest genetic risk factors for atrial fibrillation (AF) are DNA variants on chromosome 4q25 near the transcription factor genePITX2.

Atrial Fibrillation 40

Atrial Fibrillation Electrophysiology Risk Factors Arrhythmia 40

Medical Xpress - Cardiology

FEBRUARY 22, 2024

Patients who present with persistent atrial fibrillation at diagnosis are more likely to have certain risk factors as compared with patients with occasional atrial fibrillation (AFib).

AFIB 74

AFIB Risk Factors Atrial Fibrillation Electrophysiology 74

HeartRhythm

APRIL 30, 2024

Age is an independent risk factor for the development of atrial fibrillation (AF). While AF arises in old age, the combined effects of widespread structural, electrophysiological and autonomic remodeling make it difficult to discern the exact mechanisms of arrhythmia generation.

Electrophysiology 40

Electrophysiology Arrhythmia Atrial Fibrillation Risk Factors 40

Frontiers in Cardiovascular Medicine

FEBRUARY 17, 2025

Backgroundwide antral pulmonary vein isolation (PVI) is effective for treating paroxysmal atrial fibrillation (PAF), although time-demanding. Procedural data and electrophysiology (EP) laboratory times were systematically collected and analyzed.

Atrial Fibrillation 52

Atrial Fibrillation Ablation Laboratory Electrophysiology 52

HeartRhythm

SEPTEMBER 23, 2024

Atrial fibrillation (AF) is the most common arrhythmia worldwide, with increasing prevalence resulting from improved awareness, increased life expectancy, and advances in detection technology.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Heart Rhythm Electrophysiology 40

Journal of Cardiovascular Electrophysiology

NOVEMBER 3, 2024

Abstract Background and Aims Atrial fibrillation is the most prevalent cardiac arrhythmia, and catheter ablation (CA) has emerged as a viable treatment option for selected patients. However, its safety profile in liver cirrhosis (LC) populations remains underexplored.

Atrial Fibrillation 56

Atrial Fibrillation Ablation Inpatient Hospital 56

DAIC

FEBRUARY 27, 2024

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTechi , announced the commencement of patient cases with the investigational Laminar Left Atrial Appendage Elimination (LAAX) System as part of its pivotal investigational device exemption (IDE) study.

Atrial Fibrillation 105

Atrial Fibrillation Innovation AFIB Pharmacology 105

Circulation: Arrhythmia and Electrophysiology

JANUARY 29, 2024

Circulation: Arrhythmia and Electrophysiology, Ahead of Print. Three months after the index procedure, patients underwent a repeat electrophysiology study to identify pulmonary vein reconnections. Forty patients underwent a repeat electrophysiology study. or acute reconnection (4% versus 14%;P=0.3)

Electrophysiology 76

Electrophysiology Atrial Fibrillation Pulmonary Ablation 76

Circulation: Arrhythmia and Electrophysiology

FEBRUARY 10, 2025

Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:It is difficult to identify patients with atrial fibrillation (AF) most likely to respond to ablation.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Physiology Arrhythmia 40

Circulation: Arrhythmia and Electrophysiology

FEBRUARY 18, 2025

Circulation: Arrhythmia and Electrophysiology, Ahead of Print.

Atrial Fibrillation 40

Atrial Fibrillation Electrophysiology Arrhythmia Ablation 40

HeartRhythm

NOVEMBER 27, 2023

Atrial fibrillation (AF) is the most common heart arrhythmia and considered to be a progressive chronic disease associated with an increased morbidity and mortality. Recent data suggests a link between inflammation, oxidative stress and AF, although the underlying mechanisms are not fully understood.

Atrial Fibrillation 40

Atrial Fibrillation Chronic Disease Electrophysiology Arrhythmia 40

Journal of Cardiovascular Electrophysiology

JANUARY 15, 2024

Abstract Introduction Atrial fibrillation and atrial flutter originating from the donor s heart is a commonly reported complication post heart transplant. Case A 47-year-old male presented with atrial tachycardia 6 months post heart transplant. This arrhythmia was successfully terminated with radiofrequency ablation.

Atrial Fibrillation 40

Atrial Fibrillation Heart Transplant Atrial Flutter Transplant 40

Frontiers in Cardiovascular Medicine

FEBRUARY 26, 2025

BackgroundAtrial fibrillation (AF) is the most prevalent cardiac arrhythmia worldwide, posing significant health burdens. The most productive journals were Europace and the Journal of Interventional Cardiac Electrophysiology. The institution with the largest output was The Icahn School of Medicine at Mount Sinai.

Ablation 52

Ablation Atrial Fibrillation Research Electrophysiology 52

Circulation: Arrhythmia and Electrophysiology

FEBRUARY 13, 2024

Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:Atrial fibrillation is the most common cardiac arrhythmia in the world and increases the risk for stroke and morbidity.

Atrial Fibrillation 40

Atrial Fibrillation Arrhythmia Electrophysiology Circulation 40

DAIC

MARCH 26, 2024

The most common arrhythmia, atrial fibrillation , will affect approximately 12.1 Leadless pacemakers are considered the future in the treatment of heart arrhythmias and have allowed many patients to live their lives with no visible evidence of a pacemaker or heart device," said Birgersdotter-Green.

Pacemaker 105

Pacemaker Heart Rhythm Arrhythmia Atrial Fibrillation 105

Journal of Cardiovascular Electrophysiology

JANUARY 13, 2025

Studies have shown that mutations in the RYR2 gene, which encodes the RyR2 protein, are linked to several cardiac arrhythmias, including catecholaminergic polymorphic ventricular tachycardia (CPVT), long QT syndrome (LQTS), calcium release deficiency syndrome (CRDS), and atrial fibrillation (AF).

Congenital Heart Disease 40

Congenital Heart Disease Electrophysiology Congenital Heart Disease 40

DAIC

JUNE 11, 2024

In electrophysiology, innovation is king, but it is often incremental, and it almost always lacks rationale, comprehensive clinical documentation and relevance for hospitals that try to balance the increasing costs of new technology with increasing demand and reimbursement that just can’t keep pace.

Innovation 104

Innovation AFIB Technology Electrophysiology 104

Circulation: Arrhythmia and Electrophysiology

DECEMBER 19, 2024

Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:Pulsed field ablation (PFA) is a promising treatment for atrial fibrillation. One-year freedom from atrial arrhythmia was 80.2% (95% CI, 69.7%87.4%) One-year freedom from atrial arrhythmia was 80.2% (95% CI, 69.7%87.4%)

Atrial Fibrillation 40

Atrial Fibrillation Ablation Arrhythmia Outcomes 40

Frontiers in Cardiovascular Medicine

FEBRUARY 11, 2024

At present we do not have any reliable intra-procedural electrophysiologic predictors of long-term success of AF ablation other than pulmonary vein isolation. Patients were followed (median 20 months) for recurrent atrial arrhythmias as the primary end point of the study. Results PV capture was identified in 20.3%

Pulmonary 64

Pulmonary Ablation Atrial Fibrillation Electrophysiology 64

Journal of Cardiovascular Electrophysiology

MARCH 4, 2025

ABSTRACT Introduction Atrial fibrillation (AF) is the most common arrhythmia, and atrioventricular (AV) node ablation with pacemaker implantation is a therapeutic option for refractory cases. However, AV node ablation in patients with bioprosthetic tricuspid valves poses technical challenges.

Tricuspid 40

Tricuspid Atrial Fibrillation Ablation Pacemaker 40

Circulation: Arrhythmia and Electrophysiology

JANUARY 6, 2025

Circulation: Arrhythmia and Electrophysiology, Ahead of Print.

Atrial Fibrillation 40

Atrial Fibrillation Electrophysiology Arrhythmia Outcomes 40

Journal of Cardiovascular Electrophysiology

NOVEMBER 7, 2024

Catheter ablation of atrial fibrillation in infiltrative cardiomyopathies ABSTRACT Atrial and ventricular arrhythmias are common in patients with Infiltrative heart diseases. AF is the most common arrhythmia identified in patients with amyloidosis due to cellular infiltration and atrial dilation.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Cardiomyopathy Arrhythmia 40

Circulation

JANUARY 8, 2024

BACKGROUND:The relationship between heart failure (HF) and atrial fibrillation (AF) is clear, with up to half of patients with HF progressing to AF. The pathophysiological basis of AF in the context of HF is presumed to result from atrial remodeling. We found that FOG2 repressed atrial gene expression promoted byTBX5.

Atrial Fibrillation 45

Atrial Fibrillation Heart Failure Electrophysiology Arrhythmia 45

Circulation: Arrhythmia and Electrophysiology

DECEMBER 11, 2024

Circulation: Arrhythmia and Electrophysiology, Ahead of Print.

Atrial Fibrillation 40

Atrial Fibrillation Electrophysiology Arrhythmia Ablation 40

Circulation: Arrhythmia and Electrophysiology

MAY 20, 2024

Circulation: Arrhythmia and Electrophysiology, Ahead of Print.

Atrial Fibrillation 40

Atrial Fibrillation Electrophysiology Arrhythmia Circulation 40

Circulation: Arrhythmia and Electrophysiology

NOVEMBER 7, 2023

Circulation: Arrhythmia and Electrophysiology, Volume 16, Issue 11 , Page e012199, November 1, 2023. BACKGROUND:β-AR (β-adrenergic receptor) stimulation regulates atrial electrophysiology and Ca2+homeostasis via cAMP-dependent mechanisms; however, enhanced β-AR signaling can promote atrial fibrillation (AF).

Atrial Fibrillation 40

Atrial Fibrillation Electrophysiology Arrhythmia Circulation 40

Circulation: Arrhythmia and Electrophysiology

DECEMBER 19, 2024

Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:Pulmonary vein isolation (PVI) alone is less effective in patients with persistent atrial fibrillation (AF) compared with those with paroxysmal AF. to 3.4%]; hazard ratio, 0.66 [95% CI, 0.460.94]).

Atrial Fibrillation 40

Atrial Fibrillation Ablation Arrhythmia Pulmonary 40

Circulation: Arrhythmia and Electrophysiology

OCTOBER 22, 2024

Circulation: Arrhythmia and Electrophysiology, Ahead of Print.

Atrial Fibrillation 40

Atrial Fibrillation Electrophysiology Heart Failure Exercise 40

Circulation: Arrhythmia and Electrophysiology

DECEMBER 21, 2023

Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:Inflammation may promote atrial fibrillation (AF) recurrence after catheter ablation. Colchicine did not prevent atrial arrhythmia recurrence at 2 weeks (31% versus 32%; hazard ratio [HR], 0.98 [95% CI, 0.59–1.61];P=0.92)

Atrial Fibrillation 40

Atrial Fibrillation Ablation Chest Pain Atrial Flutter 40

Circulation: Arrhythmia and Electrophysiology

DECEMBER 11, 2024

Circulation: Arrhythmia and Electrophysiology, Ahead of Print.

Atrial Fibrillation 40

Atrial Fibrillation Electrophysiology Arrhythmia Circulation 40

Circulation: Arrhythmia and Electrophysiology

MARCH 5, 2024

Circulation: Arrhythmia and Electrophysiology, Ahead of Print.

Risk Factors 40

Risk Factors Atrial Fibrillation Electrophysiology Arrhythmia 40

Circulation: Arrhythmia and Electrophysiology

JANUARY 6, 2025

Circulation: Arrhythmia and Electrophysiology, Ahead of Print.

Atrial Fibrillation 40

Atrial Fibrillation Electrophysiology Arrhythmia Ablation 40

HeartRhythm

JANUARY 23, 2024

The EHRA/HRS/APHRS/SOLAECE Expert Consensus on Atrial Cardiomyopathies published in 2017 defined atrial cardiomyopathy as “any complex of structural, architectural, contractile, or electrophysiological changes affecting the atria.”1

Atrial Fibrillation 45

Atrial Fibrillation Cardiomyopathy Electrophysiology Arrhythmia 45

HeartRhythm

MAY 15, 2024

In the past decade, major advances were made in catheter ablation for arrhythmias and implantation of cardiac implantable electronic devices.1 1 Catheter ablation for atrial fibrillation (AF) and ventricular tachycardia (VT) has become the standard of care for many patients presenting with these arrhythmias.2–4

Electrophysiology 40

Electrophysiology Atrial Fibrillation Ablation Arrhythmia 40

Journal of Cardiovascular Electrophysiology

DECEMBER 7, 2023

Abstract Introduction Earlier studies have shown a clear association between severity of human immunodeficiency virus (HIV) infection and incident atrial fibrillation (AF). We present the long-term outcome of catheter ablation (CA) and electrophysiological characteristics in HIV+ AF patients. vs. 87.1%, p  = .753]

Atrial Fibrillation 40

Atrial Fibrillation Ablation Outcomes Arrhythmia 40